PA
AMED

Paralel Advisors’s Amedisys AMED Stock Holding History

Paralel Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26,002
Closed -$2.4M – 112
2024
Q1 		$2.4M Hold
26,002
– – 0.11% 57
2023
Q4 		$2.47M Hold
26,002
– – 0.13% 43
2023
Q3 		$2.43M Buy
26,002
+295
+1% +$27.3K 0.13% 29
2023
Q2 		$2.35M Buy
25,707
+15,208
+145% +$1.25M 0.13% 29
2023
Q1 		$772K Buy
10,499
+276
+3% +$23.9K 0.04% 82
2022
Q4 		$854K Buy
+10,223
New +$922K 0.05% 80

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Paralel Advisors's AMED Position: Q2 2024 in Review

Paralel Advisors sold out of Amedisys (AMED) in Q2 2024, closing a stake of 26,002 shares — an estimated $2.4M sold.

Paralel Advisors first reported a position in AMED in Q4 2022 and held it in 6 quarters. The position peaked at $2.47M in Q4 2023. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

  • Paralel Advisors reported no remaining Amedisys position as of Q2 2024 after selling out during the quarter.
  • Paralel Advisors sold 26,002 Amedisys shares in Q2 2024, an estimated $2.4M.
  • Paralel Advisors first reported a position in Amedisys in Q4 2022 and held it in 6 quarters.
  • Paralel Advisors's Amedisys position peaked at $2.47M in Q4 2023.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on Paralel Advisors's 13F filing for Q2 2024, filed 6 Aug 2024.